Kairos Pharma, LTD. (KAPA) › Operating IncomeKairos Pharma, LTD. (KAPA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2023: -$1.71M2024: -$2.34M2025: -$5.57M-$5.57M2023Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$5.57M-137.8%2024-$2.34M-36.7%2023-$1.71M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share